Found: 18
Select item for more details and to access through your institution.
Differentiation of 2‐hydroxyglutarate enantiomers and its lactones by gas chromatography/electron ionization tandem mass spectrometry.
- Published in:
- Rapid Communications in Mass Spectrometry: RCM, 2019, v. 33, n. 17, p. 1401, doi. 10.1002/rcm.8485
- By:
- Publication type:
- Article
A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 10, p. 1505, doi. 10.1093/neuonc/noaa062
- By:
- Publication type:
- Article
Liquid biopsy in central nervous system metastases: a RANO review and proposals for clinical applications.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 5, p. 571, doi. 10.1093/neuonc/noz012
- By:
- Publication type:
- Article
Leptomeningeal metastases: a RANO proposal for response criteria.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 4, p. 484, doi. 10.1093/neuonc/now183
- By:
- Publication type:
- Article
A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study.
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 6, p. 854, doi. 10.1093/neuonc/nou348
- By:
- Publication type:
- Article
Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma.
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 2, p. 266, doi. 10.1093/neuonc/nou155
- By:
- Publication type:
- Article
Leptomeningeal metastasis: a Response Assessment in Neuro-Oncology critical review of endpoints and response criteria of published randomized clinical trials.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. 9, p. 1176, doi. 10.1093/neuonc/nou089
- By:
- Publication type:
- Article
Phase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas: North American Brain Tumor Consortium trial 04-02.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. 4, p. 567, doi. 10.1093/neuonc/not247
- By:
- Publication type:
- Article
A phase I factorial design study of dose-dense temozolomide alone and in combination with thalidomide, isotretinoin, and/or celecoxib as postchemoradiation adjuvant therapy for newly diagnosed glioblastoma.
- Published in:
- Neuro-Oncology, 2010, v. 12, n. 11, p. 1167, doi. 10.1093/neuonc/noq100
- By:
- Publication type:
- Article
13-cis -Retinoic acid in the treatment of recurrent glioblastoma multiforme.
- Published in:
- Neuro-Oncology, 2004, v. 6, n. 3, p. 253, doi. 10.1215/S1152851703000607
- By:
- Publication type:
- Article
Neoplastic meningitis in patients with adenocarcinoma of the gastrointestinal tract.
- Published in:
- Cancer (0008543X), 2005, v. 103, n. 11, p. 2355, doi. 10.1002/cncr.21082
- By:
- Publication type:
- Article
The Identification and Characterization of Breast Cancer CTCs Competent for Brain Metastasis.
- Published in:
- Science Translational Medicine, 2013, v. 5, n. 180, p. 1, doi. 10.1126/scitranslmed.3005109
- By:
- Publication type:
- Article
Reply to Unexpectedly low rates of neuropsychiatric adverse effects associated with mefloquine repurposed for the treatment of glioblastoma.
- Published in:
- Cancer (0008543X), 2019, v. 125, n. 8, p. 1385, doi. 10.1002/cncr.31960
- By:
- Publication type:
- Article
Reply to Unexpectedly low rates of neuropsychiatric adverse effects associated with mefloquine repurposed for the treatment of glioblastoma.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Phase 1 lead-in to a phase 2 factorial study of temozolomide plus memantine, mefloquine, and metformin as postradiation adjuvant therapy for newly diagnosed glioblastoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Phase 2 trial of irinotecan and thalidomide in adults with recurrent anaplastic glioma.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 14, p. 3599, doi. 10.1002/cncr.26663
- By:
- Publication type:
- Article
Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancer.
- Published in:
- Journal of Neuro-Oncology, 2020, v. 148, n. 3, p. 599, doi. 10.1007/s11060-020-03555-z
- By:
- Publication type:
- Article
Biomarkers of disease: cerebrospinal fluid vascular endothelial growth factor (VEGF) and stromal cell derived factor (SDF)-1 levels in patients with neoplastic meningitis (NM) due to breast cancer, lung cancer and melanoma.
- Published in:
- Journal of Neuro-Oncology, 2009, v. 94, n. 2, p. 229, doi. 10.1007/s11060-009-9819-2
- By:
- Publication type:
- Article